Re: flowcap's comments - as far as "Technical" analysis goes, _any_one can say _any_thing and show charts to "prove" it. I can also show charts to _dis_prove it.
We are at a time now where _every_one, from the smartest analysts and money managers, to the elementary school kid doing a portfolio management project, is using this kind of "Technical" analysis. But maybe - just maybe - the tide is turning in favor of fundamental analysis now. And maybe - just maybe - things like business plans, cash flow, cash hoard, product slate, R&D, stability, dividend, international presence.....all of that will matter.
As for the prediction that it will go down and "test the lows again"... who knows - or cares - it may or may not happen. The more important issue is upside vs. downside risk. My approach is to scale in slowly, and keep increasing my position if it continues to go down.
-
Re: flowcap's comments - as far as "Technical" analysis goes, _any_one can say _any_thing and show charts to "prove" it. I can also show charts to _dis_prove it.
Aug 25 04:53 am
|Rating:
0
0
All Comments by WorkerOnWallStreet »The Long Case for Pfizer [View article]
We are at a time now where _every_one, from the smartest analysts and money managers, to the elementary school kid doing a portfolio management project, is using this kind of "Technical" analysis. But maybe - just maybe - the tide is turning in favor of fundamental analysis now. And maybe - just maybe - things like business plans, cash flow, cash hoard, product slate, R&D, stability, dividend, international presence.....all of that will matter.
As for the prediction that it will go down and "test the lows again"... who knows - or cares - it may or may not happen. The more important issue is upside vs. downside risk. My approach is to scale in slowly, and keep increasing my position if it continues to go down.